01-07-2025 07:53 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Smart Quotes
Mankind Pharma Ltd.
 
  Industry : Pharmaceuticals & Drugs
BSE Code 543904
ISIN Demat INE634S01028
Book Value 354.72
NSE Code MANKIND
Dividend Yield % 0.00
Market Cap 958686.34
P/E 50.88
EPS 45.65
Face Value 1  
30-Jun-2025
Last Price 2322.80  
Net Change -11.45  
% Change -0.49%  
Prev.Close 2334.25  
Open 2347.65  
High 2347.65  
Low  2310.00
Volume  5771
Value  13393798
Best Buy 0.00  
Best Sell 0.00  
Best Quantity 0  
Sell Quantity 0  
Today's Range 2347.65  
52-Week High 3050.00  
52-Week Low 1910.10  
You need to upgrade your Flash Player
1 Day   | 1 Mon   | 3 Mon   | 1Year
                                                                                   
Best Bid   Best Offer
Quantity 0  
Price 0.00  
Quantity 0  
Price 0.00  
Holding Details
More
Latest Corporate Events
Company News
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.